Silo Pharma Inc.成功获得澳大利亚专利,该专利覆盖其授权的创伤后应激障碍(PTSD)药物候选物,进一步扩展了公司的全球知识产权组合。
Silo Pharma Inc.成功获得澳大利亚专利,该专利覆盖其授权的创伤后应激障碍(PTSD)药物候选物,进一步扩展了公司的全球知识产权组合。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.